We need to mandate drug cost transparency on electronic medical records

CMAJ. 2017 Dec 18;189(50):E1541-E1542. doi: 10.1503/cmaj.171070.

Authors

Iris Gorfinkel¹, Joel Lexchin²

Affiliations

¹ PrimeHealth Clinical Research - Family Practice (Gorfinkel); School of Health Policy and Management (Lexchin), Faculty of Health, York University, Toronto, Ont. i.gor@outlook.com.
² PrimeHealth Clinical Research - Family Practice (Gorfinkel); School of Health Policy and Management (Lexchin), Faculty of Health, York University, Toronto, Ont.

No abstract available

MeSH terms

Access to Information*
Canada
Cost-Benefit Analysis
Drug Costs*
Electronic Health Records* / economics
Electronic Health Records* / organization & administration
Healthcare Financing
Humans